We noted a trend, although not statistically significant, of an increased incidence of CIP among former and current smokers, high PD-L1 expressers, squamous histology, patients with COPD, and those receiving pembrolizumab-based therapy. The gene discussed is CD274; the disease is chronic obstructive pulmonary disease.